Publications by authors named "Alessia Piacevole"

Chronic kidney disease (CKD) represents a significant global health challenge, affecting millions of individuals and leading to substantial morbidity and mortality. This review aims to explore the epidemiology, cardiovascular complications, and management strategies associated with CKD, emphasizing the importance of preventing cardiovascular disease and early intervention. CKD is primarily driven by conditions such as diabetes mellitus, hypertension, and cardiovascular diseases, which often coexist and exacerbate renal impairment.

View Article and Find Full Text PDF

Type 2 diabetes mellitus (T2DM) is a prevalent chronic metabolic disorder characterized by insulin resistance and progressive beta cell dysfunction, presenting substantial global health and economic challenges. This review explores recent advancements in diabetes management, emphasizing novel pharmacological therapies and their physiological mechanisms. We highlight the transformative impact of Sodium-Glucose Cotransporter 2 inhibitor (SGLT2i) and Glucagon-Like Peptide 1 Receptor Agonist (GLP-1RA), which target specific physiological pathways to enhance glucose regulation and metabolic health.

View Article and Find Full Text PDF
Article Synopsis
  • - Diabetic neuropathy (DN) is a common complication of both type 1 and type 2 diabetes, often starting earlier in type 2 diabetes patients and developing several years after diagnosis in type 1 diabetes patients.
  • - It can affect both sensory-motor and autonomic nerve fibers, leading to a range of symptoms, with lower limb pain being a frequent complaint.
  • - The exact causes of DN are still not fully understood, but factors like high blood sugar and reduced blood supply to nerves can contribute to nerve damage; this review aims to explore recent findings related to DN's causes and diagnosis.
View Article and Find Full Text PDF

People who use drugs (PWUDs) are a crucial population in the global fight against viral hepatitis. The difficulties in linkage to care, the low adherence to therapy, the frequent loss to follow-up and the high risk of re-infection make the eradication process of the hepatitis C virus (HCV) really hard in this viral reservoir. Several management and treatment models have been tested with the aim of optimizing the HCV care cascade in PWUDs.

View Article and Find Full Text PDF